Showing 2991-3000 of 3315 results for "".
- Insight Into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracyhttps://modernod.com/news/insight-into-fdas-revised-policy-on-antibody-tests-prioritizing-access-and-accuracy/2477725/In a blog post on the FDA website, agency leaders outlined a new policy that aims to provide more oversight of COVID-19 antibody tests. The revised policy on antibody tests was written by Anand Shah, MD, Deputy Commissioner for Medical and Scientific Affairs, and Jeff Shuren, MD, Director,
- Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophyhttps://modernod.com/news/lineage-cell-therapeutics-reports-new-data-with-opregen-for-the-treatment-of-dry-amd-with-geographic-atrophy/2477713/Lineage Cell Therapeutics announced that updated results from a phase 1/2a study of its lead product candidate OpRegen, a retinal pigment epithelium (RPE) cell transplant therapy currently in development for the treatment of dry age-related macular degeneration (AMD), were published online via th
- Kala Pharmaceuticals Resubmits NDA for Eysuvis for Dry Eye Diseasehttps://modernod.com/news/kala-pharmaceuticals-resubmits-nda-for-eysuvis-for-dry-eye-disease/2477696/Kala Pharmaceuticals announced that it has resubmitted its new drug application (NDA) to the FDA for Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25%, a product candidate for the short-term treatment of the signs and symptoms of dry eye disease. Kala believes this application will be c
- Diabetic Retinopathy Approaches Refined by New Trial Resultshttps://modernod.com/news/diabetic-retinopathy-approaches-refined-by-new-trial-results/2477686/Data from clinical trials are prompting leading diabetic retinopathy specialists to change their approach to treatment, according to a Medscape report. The Protocol studies conducted by the DRCR Retina Network, which is funded by t
- Gilead Says Early Results of Coronavirus Drug Trial Show Improvement With Shorter Remdesivir Treatmenthttps://modernod.com/news/gilead-says-early-results-of-coronavirus-drug-trial-show-improvement-with-shorter-remdesivir-treatment/2477673/Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks, according to a CNBC
- AAPS: Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patientshttps://modernod.com/news/aaps-hydroxychloroquine-has-about-90-percent-chance-of-helping-covid-19-patients/2477670/In a letter to Gov. Doug Ducey of Arizona, the Association of American Physicians and Surgeons (AAPS) presented a
- Foundation Fighting Blindness To Jointly Host Online CME, COPE Webinarhttps://modernod.com/news/foundation-fighting-blindness-to-jointly-host-online-cme-cope-webinar/2477657/The Foundation Fighting Blindness has announced it will host its first continuing medical education (CME and COPE) event. The distance-learning course will be hosted on Monday, May 18, 2020 at 12 pm eastern time. The course will cover inherited retinal diseases (IRDs), Foundation resources, and c
- Ziemer Receives CE Mark Clearance For Two New Applications For the Femto LDV Z8 Laser Platformhttps://modernod.com/news/ziemer-receives-ce-mark-clearance-for-two-new-applications-for-the-femto-ldv-z8-laser-platform/2477654/After several years of development, Ziemer has received CE clearance for its new lenticule application called CLEAR (Corneal Lenticule Extraction for Advanced Refractive Correction). The new proprietary application is
- Johnson & Johnson Vision Appoints Rajesh K. Rajpal, MD, Chief Medical Officerhttps://modernod.com/news/johnson-johnson-vision-appoints-rajesh-k-rajpal-md-chief-medical-officer/2477634/Johnson & Johnson Vision has appointed Rajesh K. Rajpal, MD, as Chief Medical Officer and Global Head of Clinical and Medical Affairs. In this role, Dr. Rajpal will lead the integration of rapidly evolving medical and clinical insights into new product development to address unmet needs of pa
- Congress Reaches Deal That Includes $75B for Hospitals After Requests From Providershttps://modernod.com/news/congress-reaches-deal-that-includes-75b-for-hospitals-after-requests-from-providers/2477629/Congressional and White House leaders have reached a deal to provide $75 billion for hospitals and another $25 billion for testing, according to a report from CNN, as